DENTSPLY SIRONA Inc
XMUN:DY2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
DENTSPLY SIRONA Inc
XMUN:DY2
|
US |
|
C
|
Conagra Brands Inc
DUS:CAO
|
US |
|
Zurich Insurance Group AG
OTC:ZURVY
|
CH |
|
H2APEX Group SCA
XETRA:H2A
|
LU |
|
N
|
Next PLC
OTC:NXGPF
|
UK |
|
Watts Water Technologies Inc
NYSE:WTS
|
US |
DENTSPLY SIRONA Inc
DENTSPLY SIRONA makes equipment and supplies for dentists and dental labs. Its products include imaging systems, dental chairs and treatment units, drill and handpiece tools, digital scanning and design systems, implant parts, and everyday consumables such as endodontic and restorative materials. It also sells service, software, and replacement parts to keep those systems running. Its main customers are dental practices, clinics, dental laboratories, and distributors that serve those buyers. The company makes money by selling a mix of higher-ticket equipment and recurring consumable products, which means customers may buy a system once but keep coming back for materials, accessories, and service support over time. What makes the business model distinct is that it sits close to the core of dental care: it supplies both the devices used in the chair and the materials used in treatment. That gives it a broad role in the dental workflow, from diagnosis and planning to treatment and maintenance, rather than relying on just one narrow product category.
DENTSPLY SIRONA makes equipment and supplies for dentists and dental labs. Its products include imaging systems, dental chairs and treatment units, drill and handpiece tools, digital scanning and design systems, implant parts, and everyday consumables such as endodontic and restorative materials. It also sells service, software, and replacement parts to keep those systems running.
Its main customers are dental practices, clinics, dental laboratories, and distributors that serve those buyers. The company makes money by selling a mix of higher-ticket equipment and recurring consumable products, which means customers may buy a system once but keep coming back for materials, accessories, and service support over time.
What makes the business model distinct is that it sits close to the core of dental care: it supplies both the devices used in the chair and the materials used in treatment. That gives it a broad role in the dental workflow, from diagnosis and planning to treatment and maintenance, rather than relying on just one narrow product category.
Revenue: Q2 revenue was $898 million, down 4.1% reported and 6.3% constant currency. Management said the decline was partly affected by Byte and a planned dealer inventory reduction.
Margins: Adjusted EBITDA margin was roughly flat year over year, helped by $44 million of tariff refunds but pressured by lower volumes, mix, and incremental tariffs.
Outlook: The company kept its 2026 guidance at $3.5 billion to $3.6 billion of net sales and adjusted EPS of $1.40 to $1.50, with Q3 expected to be weaker than Q2.
Turnaround: Management said the Return-to-Growth plan is starting to show traction, but most of the improvement is expected to come later in the year, especially in Q4.
Capital allocation: Dentsply Sirona repurchased 1.3 million shares for about $12 million, its first buyback since Q3 2024, while still prioritizing debt reduction.
Regional mix: U.S. performance remains the main turnaround focus, while EMEA was hurt by distributor inventory changes and capital equipment delays tied to Middle East uncertainty.
Wellspect: Wellspect continued to stand out, with 7.1% reported growth driven by new products and execution.
